Perspective Therapeutics (CATX) Profit After Tax (2010 - 2026)

Perspective Therapeutics recorded quarterly Profit After Tax of -$26.2 million in Q1 2026, up 30.14% quarter-over-quarter from -$37.5 million in Q4 2025, and down 44.08% year-over-year from -$46.8 million in Q1 2025.

Perspective Therapeutics' Profit After Tax history runs 17 years deep, the most recent figure standing at -$26.2 million for Q1 2026.

  • In Q1 2026, Profit After Tax fell 44.08% year-over-year to -$26.2 million; the TTM figure through Mar 2026 stood at -$111.1 million (down 30.48% YoY), while the FY2025 annual figure was -$103.1 million, down 30.07% from the prior year.
  • Profit After Tax came in at -$26.2 million for Q1 2026 at Perspective Therapeutics, up from -$37.5 million in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of -$371000.0 in Q1 2023 to a low of -$40.2 million in Q4 2024.
  • A 5-year average of -$15.9 million and a median of -$12.3 million in 2024 frame the typical range for Profit After Tax.
  • Across the five-year window, Profit After Tax surged 72.46% in 2023 and tumbled 3211.05% in 2024, its largest moves.
  • Perspective Therapeutics' Profit After Tax stood at -$7.3 million in 2022, then plunged by 236.4% to -$24.7 million in 2023, then tumbled by 62.79% to -$40.2 million in 2024, then climbed by 6.67% to -$37.5 million in 2025, then surged by 30.14% to -$26.2 million in 2026.
  • According to Business Quant data, Profit After Tax over the past three periods registered -$26.2 million, -$37.5 million, and -$26.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 1.08 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 745.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 1.14 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 380.70 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 170.93 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 199.50 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 411.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 220.30 Mn
10 Perspective Therapeutics 380.23 Mn 380.23 Mn - -26.19 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -26.19 Mn
Dec 31, 2025 -37.49 Mn
Sep 30, 2025 -25.97 Mn
Jun 30, 2025 -21.49 Mn
Mar 31, 2025 -18.18 Mn
Dec 31, 2024 -40.17 Mn
Sep 30, 2024 -15.12 Mn
Jun 30, 2024 -11.70 Mn
Mar 31, 2024 -12.28 Mn
Dec 31, 2023 -24.68 Mn
Sep 30, 2023 -10.36 Mn
Jun 30, 2023 -11.11 Mn
Mar 31, 2023 -371,000.00
Dec 31, 2022 -7.34 Mn
Sep 30, 2022 -4.07 Mn
Jun 30, 2022 -2.08 Mn
Mar 31, 2022 -1.35 Mn
Dec 31, 2021 -1.60 Mn
Sep 30, 2021 -2.24 Mn
Jun 30, 2021 -1.06 Mn
Mar 31, 2021 -745,000.00
Dec 31, 2020 -868,000.00
Sep 30, 2020 -713,000.00
Jun 30, 2020 -1.19 Mn
Mar 31, 2020 -545,000.00
Dec 31, 2019 -897,000.00
Sep 30, 2019 -816,000.00
Jun 30, 2019 -1.10 Mn
Mar 31, 2019 -1.13 Mn
Dec 31, 2018 -1.41 Mn
Sep 30, 2018 -1.51 Mn
Jun 30, 2018 -2.34 Mn
Mar 31, 2018 -1.33 Mn
Dec 31, 2017 -1.46 Mn
Sep 30, 2017 -1.55 Mn
Jun 30, 2017 -1.85 Mn
Mar 31, 2017 -1.36 Mn
Dec 31, 2016 -1.45 Mn
Sep 30, 2016 -1.50 Mn
Jun 30, 2016 -1.19 Mn
Mar 31, 2016 -1.20 Mn
Dec 31, 2015 -1.31 Mn
Sep 30, 2015 -1.02 Mn
Jun 30, 2015 -1.03 Mn
Mar 31, 2015 -953,553.00
Dec 31, 2014 -906,954.00
Sep 30, 2014 -785,862.00
Jun 30, 2014 -1.68 Mn
Mar 31, 2014 -2.08 Mn
Dec 31, 2013 -926,972.00
Sep 30, 2013 -1.27 Mn
Jun 30, 2013 -993,564.00
Mar 31, 2013 -715,037.00
Dec 31, 2012 -1.15 Mn
Sep 30, 2012 -993,668.00
Jun 30, 2012 -1.20 Mn
Mar 31, 2012 -552,886.00
Dec 31, 2011 -628,745.00
Sep 30, 2011 -1.10 Mn
Jun 30, 2011 -711,997.00
Mar 31, 2011 -1.03 Mn
Dec 31, 2010 -228,069.00
Sep 30, 2010 -871,882.00